FEMARA 2.5

$62.00

Manufacturer: Dragon Pharma
Category: Oral Steroids
Substance: Letrozole
Package: 30 tabs (2,5 mg/tab)

Out of stock

Category:

Description

Properties of Femara 2.5

Letrozole is one of the best nonsteroidal drugs for reducing the estrogenic activity caused by anabolic steroids. Also known as Femara 2.5. It is an aromatase inhibitor and is widely used in bodybuilding. Just letrozole:

  • Increases anabolic hormones in the blood
  • Reduces estrogenic activity by suppressing the axis of the G ‑ G – Z
  • Lowers estrogen concentration
  • Increases the level of LH (luteinizing hormone)
  • Eliminates the manifestation of gynecomastia on the course
  • It has anti-cytabolic properties that prevent the destruction of muscle tissue.
  • Prevents hypertension

Femara 2.5 instruction

Predominantly Femara 2.5 tablets is used on the course and before PKT, but can also be used before the course to reduce estrogenic activity. Recommended dosages from 1 to 3 mg per day. The drug can be used at any time of the day, preferably after meals.
The dosage is calculated individually depending on the parameters of the athlete: Age, height, weight, etc.
The optimal dosage for the prevention of gynecomastia is 0.5-1 mg once a day. When signs of gynecomastia appear, the dosage is 2.5 mg (1 tablet) daily until symptoms disappear.
The drug should be used if there are aromatic steroids in the course: methane, any testosterone esters (enanthate, propionate, sustanon, cypionate), etc.
The half-life of the drug is 3 days, which allows you to take it once every 2 days. It has been proven that a dosage of 1 mg reduces estradiol levels by 60%.

Side Effects of Letrozole Femara 2.5 mg

  • Bone Strength Reduction
  • Blood pressure increase
  • Hair loss
  • Decreased libido
  • Nausea
  • Temperature rise
  • Increase cholesterol

It is worth noting that the drug is safe and does not entail negative side effects, if you do not exceed the recommended dosage and frequency of administration. The manifestation of side effects suggests that estrogen levels are excessively depressed and the drug should be discontinued or the dosage should be reduced.

Additional information

Brand

Package

Substance

Have no product in the cart!
0